InspireMD Initiates U.S. Recall of CGuard Prime System
MIAMI, May 1, 2026 InspireMD, Inc. announced a voluntary U.S. recall of its CGuard® Prime 135 cm carotid stent...
TCAR
Advertisement
InspireMD, Inc. Secures FDA IDE for CGUARDIANS III
MIAMI, May 1, 2026 InspireMD, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its...
Advertisement
